Patents by Inventor John R. Klaehn

John R. Klaehn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7772361
    Abstract: A PBI compound that includes imidazole nitrogens, at least a portion of which are substituted with an organic-inorganic hybrid moiety. At least 85% of the imidazole nitrogens may be substituted. The organic-inorganic hybrid moiety may be an organosilane moiety, for example, (R)Me2SiCH2—, where R is selected from among methyl, phenyl, vinyl, and allyl. The PBI compound may exhibit similar thermal properties in comparison to the unsubstituted PBI. The PBI compound may exhibit a solubility in an organic solvent greater than the solubility of the unsubstituted PBI. The PBI compound may be included in separatory media. A substituted PBI synthesis method may include providing a parent PBI in a less than 5 wt % solvent solution. Substituting may occur at about room temperature and/or at about atmospheric pressure. Substituting may use at least five equivalents in relation to the imidazole nitrogens to be substituted or, preferably, about fifteen equivalents.
    Type: Grant
    Filed: July 3, 2007
    Date of Patent: August 10, 2010
    Assignee: Battelle Energy Alliance, LLC
    Inventors: John R. Klaehn, Eric S. Peterson, Alan K. Wertsching, Christopher J. Orme, Thomas A. Luther, Michael G. Jones
  • Publication number: 20100150798
    Abstract: Methods of separating actinides from lanthanides are disclosed. A regio-specific/stereo-specific dithiophosphinic acid having organic moieties is provided in an organic solvent that is then contacted with an acidic medium containing an actinide and a lanthanide. The method can extend to separating actinides from one another. Actinides are extracted as a complex with the dithiophosphinic acid. Separation compositions include an aqueous phase, an organic phase, dithiophosphinic acid, and at least one actinide. The compositions may include additional actinides and/or lanthanides. A method of producing a dithiophosphinic acid comprising at least two organic moieties selected from aromatics and alkyls, each moiety having at least one functional group is also disclosed. A source of sulfur is reacted with a halophosphine. An ammonium salt of the dithiophosphinic acid product is precipitated out of the reaction mixture. The precipitated salt is dissolved in ether.
    Type: Application
    Filed: September 11, 2006
    Publication date: June 17, 2010
    Inventors: Dean R. Peterman, John R. Klaehn, Mason K. Harrup, Richard D. Tillotson, Jack D. Law
  • Patent number: 7704468
    Abstract: An extraction agent for the separation of trivalent actinides from lanthanides in an acidic media and a method for forming same are described, and wherein the methodology produces a stable regiospecific and/or stereospecific dithiophosphinic acid that can operate in an acidic media having a pH of less than about 7.
    Type: Grant
    Filed: September 21, 2005
    Date of Patent: April 27, 2010
    Assignee: Battelle Energy Alliance, LLC
    Inventors: John R. Klaehn, Mason K. Harrup, Jack D. Law, Dean R. Peterman
  • Publication number: 20100094042
    Abstract: An extraction agent for the separation of trivalent actinides from lanthanides in an acidic media and a method for forming same are described, and wherein the methodology produces a stable regiospecific and/or stereospecific dithiophosphinic acid that can operate in an acidic media having a pH of less than about 7.
    Type: Application
    Filed: September 21, 2005
    Publication date: April 15, 2010
    Inventors: John R. Klaehn, Mason K. Harrup, Jack D. Law, Dean R. Peterman
  • Patent number: 7632898
    Abstract: A PBI compound includes imidazole nitrogens at least a portion of which are substituted with an organic-inorganic hybrid moiety may be included in a separatory medium. At least 85% of the imidazole nitrogens may be substituted. The organic-inorganic hybrid moiety may be an organosilane moiety, for example, (R)Me2SiCH2— where R is selected from among methyl, phenyl, vinyl, and allyl. The separatory medium may exhibit an H2, Ar, N2, O2, CH3, or CO2 gas permeability greater than the gas permeability of a comparable separatory medium comprising the PBI compound without substitution. The separatory medium may further include an electronically conductive medium and/or an ionically conductive medium. The separatory medium may be used as a membrane (semi-permeable, permeable, and non-permeable), a barrier, an ion exchange media, a filter, a gas chromatography coating (such as stationary phase coating in affinity chromatography), etc.
    Type: Grant
    Filed: July 3, 2007
    Date of Patent: December 15, 2009
    Assignee: Battelle Energy Alliance, LLC
    Inventors: John R. Klaehn, Eric S. Peterson, Alan K. Wertsching, Christopher J. Orme, Thomas A. Luther, Michael G. Jones
  • Publication number: 20090012253
    Abstract: A PBI compound includes imidazole nitrogens at least a portion of which are substituted with an organic-inorganic hybrid moiety. At least 85% of the imidazole nitrogens may be substituted. The organic-inorganic hybrid moiety may be an organosilane moiety, for example, (R)Me2SiCH2— where R is selected from among methyl, phenyl, vinyl, and allyl. The PBI compound may exhibit similar thermal properties in comparison to the unsubstituted PBI. The PBI compound may exhibit a solubility in an organic solvent greater than the solubility of the unsubstituted PBI. The PBI compound may be included in separatory media. A substituted PBI synthesis method may include providing a parent PBI in a less than 5 wt % solvent solution. Substituting may occur at about room temperature and/or at about atmospheric pressure. Substituting may use at least 5 equivalents in relation to the imidazole nitrogens to be substituted or, preferably, about 15.
    Type: Application
    Filed: July 3, 2007
    Publication date: January 8, 2009
    Inventors: John R. Klaehn, Eric S. Peterson, Alan K. Wertsching, Christopher J. Orme, Thomas A. Luther, Michael G. Jones
  • Publication number: 20090012190
    Abstract: A PBI compound includes imidazole nitrogens at least a portion of which are substituted with an organic-inorganic hybrid moiety. At least 85% of the imidazole nitrogens may be substituted. The organic-inorganic hybrid moiety may be an organosilane moiety, for example, (R)Me2SiCH2— where R is selected from among methyl, phenyl, vinyl, and allyl. The PBI compound may exhibit similar thermal properties in comparison to the unsubstituted PBI. The PBI compound may exhibit a solubility in an organic solvent greater than the solubility of the unsubstituted PBI. The PBI compound may be included in separatory media. A substituted PBI synthesis method may include providing a parent PBI in a less than 5 wt % solvent solution. Substituting may occur at about room temperature and/or at about atmospheric pressure. Substituting may use at least 5 equivalents in relation to the imidazole nitrogens to be substituted or, preferably, about 15.
    Type: Application
    Filed: July 3, 2007
    Publication date: January 8, 2009
    Inventors: John R. Klaehn, Eric S. Peterson, Alan K. Wertsching, Christopher J. Orme, Thomas A. Luther, Michael G. Jones
  • Patent number: 7309758
    Abstract: A PBI compound includes imidazole nitrogens at least a portion of which are substituted with a moiety containing a carbonyl group, the substituted imidazole nitrogens being bonded to carbon of the carbonyl group. At least 85% of the nitrogens may be substituted. The carbonyl-containing moiety may include RCO—, where R is alkoxy or haloalkyl. The PBI compound may exhibit a first temperature marking an onset of weight loss corresponding to reversion of the substituted PBI that is less than a second temperature marking an onset of decomposition of an otherwise identical PBI compound without the substituted moiety. The PBI compound may be included in separatory media. A substituted PBI synthesis method may include providing a parent PBI in a less than 5 wt % solvent solution. Substituting may use more than 5 equivalents in relation to the imidazole nitrogens to be substituted.
    Type: Grant
    Filed: October 19, 2004
    Date of Patent: December 18, 2007
    Assignee: Battelle Energy Alliance, LLC
    Inventors: John R. Klaehn, Eric S. Peterson, Christopher J. Orme, Michael G. Jones, Alan K. Wertsching, Thomas A. Luther, Tammy L. Trowbridge
  • Patent number: 7259230
    Abstract: A PBI compound includes imidazole nitrogens at least a portion of which are substituted with an organic-inorganic hybrid moiety. At least 85% of the imidazole nitrogens may be substituted. The organic-inorganic hybrid moiety may be an organosilane moiety, for example, (R)Me2SiCH2— where R is selected from among methyl, phenyl, vinyl, and allyl. The PBI compound may exhibit similar thermal properties in comparison to the unsubstituted PBI. The PBI compound may exhibit a solubility in an organic solvent greater than the solubility of the unsubstituted PBI. The PBI compound may be included in separatory media. A substituted PBI synthesis method may include providing a parent PBI in a less than 5 wt % solvent solution. Substituting may occur at about room temperature and/or at about atmospheric pressure. Substituting may use at least 5 equivalents in relation to the imidazole nitrogens to be substituted or, preferably, about 15.
    Type: Grant
    Filed: June 7, 2004
    Date of Patent: August 21, 2007
    Assignee: Battelle Energy Alliance, LLC
    Inventors: John R. Klaehn, Eric S. Peterson, Alan K. Wertsching, Christopher J. Orme, Thomas A. Luther, Michael G. Jones